Vismodegib (GDC-0449) Mechanism of Action: SMO Inhibition in Basal Cell Carcinoma Cells Research

Vismodegib (GDC-0449) MOA:Targeting SMO/Hedgehog Signaling Pathway for Advanced Basal Cell Carcinoma Treatment and Combination Therapies

🎯 check Vismodegib (GDC-0449) product page

Vismodegib (GDC-0449) is a potent, small-molecule Smoothened (SMO) antagonist. It affects the Hedgehog (Hh) signaling pathway by binding to the SMO receptor and blocking downstream GLI activation, thereby inhibiting cancer cell proliferation, invasion, and inducing apoptosis.

Primary Applications and Mechanism of Action